日本欧美中文在线观看,亚洲欧洲精品成人久久奇米网,99精品欧美一区二区三区综合,中文字幕丰满乱子无码视频

設(shè)為主頁 加入收藏 聯(lián)系我們

公司公告

更多公告>>
技術(shù)文章
當(dāng)前位置:首頁 > 技術(shù)文章 > 賽諾菲投資7億美元支持Alnylam開發(fā)RNAi療法
賽諾菲投資7億美元支持Alnylam開發(fā)RNAi療法
點(diǎn)擊次數(shù):1302 更新時(shí)間:2014-01-14

    2014年1月14日賽諾菲宣布將擴(kuò)大與Alnylam公司在RNAi研究領(lǐng)域的合作。公司將投入約7億美元收購Ainylam公司約12%的股份以支持其目前處于研發(fā)階 段的各種研究項(xiàng)目。這一動(dòng)作同時(shí)也標(biāo)志著賽諾菲在波士頓地區(qū)繼續(xù)擴(kuò)大影響。公司此前以200億美元的價(jià)格收購了Genzyme公司,而Genzyme公司將與Ainylam在RNAi領(lǐng)域開始密切配合。

    事實(shí)上,不僅僅是賽諾菲,一些制藥*都已經(jīng)開始表現(xiàn)出重返RNAi療法研究的跡象。例如羅氏公司剛剛簽訂了第二份關(guān)于RNAi研究的合作協(xié)議。這些跡象都暗示著今后這些醫(yī)藥研發(fā)*將可能向RNAi療法這一研究領(lǐng)域投入巨大精力。

詳細(xì)英文報(bào)道:

Sanofi is doubling down on its RNAi development deal with Alnylam. The pharma giant ($SNY) says it will pay a hefty premium to buy up a 12% stake in the biotech, investing $700 million and greatly expanding its rights to Alnylam's ($ALNY) lead drug along with a portfolio of current and prospective therapies.

The deal highlights Big Pharma's return to RNAi, a new technology for gene silencing that experienced a deep chill several years ago as Roche ($RHHBY) and others bowed out of the field. But Roche recently struck its second RNAi pact and Sanofi clearly believes that the industry is nearing some critical product-development milestones.

The expanded partnership also spotlights Sanofi's growing involvement in the Boston hub, where it paid $20 billion for Genzyme and its rare disease drugs. Now the Genzyme subsidiary will work with Alnylam on patisiran, in development for TTR-familial amyloid polyneuropathy, gaining marketing rights outside of North America and Europe. Sanofi also gains marketing rights to three other therapies in the pipeline while nabbing options on all other products that treat rare diseases.

Alnylam execs have been one of the chief proponents of RNAi as the next big product arena, with potential to rival monoclonal antibodies in terms of revenue potential. And they clearly relished the opportunity to boast about the new deal at the beginning of the big JPMorgan conference in San Francisco.

"RNAi therapeutics now have the opportunity to be the next product platform," Alnylam COO Barry Greene told Reuters.——(華雅干細(xì)胞整理報(bào)道)

座機(jī):
023-63419609
聯(lián)系方式:
15021010459
點(diǎn)擊這里給我發(fā)消息
 

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站
九龙县| 瑞安市| 卢湾区| 永登县| 牙克石市| 介休市| 绥江县| 年辖:市辖区| 娱乐| 都匀市| 金华市| 奈曼旗| 青阳县| 巫溪县| 渭南市| 刚察县| 嘉兴市| 江华| 余姚市| 准格尔旗| 内黄县| 黄龙县| 库车县| 新泰市| 马鞍山市| 芷江| 开封县| 乌兰浩特市| 驻马店市| 望城县| 磐石市| 巩留县| 延津县| 南昌市| 台南县| 平塘县| 青神县| 莒南县| 庆城县| 新干县| 文化|